Aston Sci Overview

  • Founded
  • 2018
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series C
  • Latest Deal Amount
  • $22.8M
Latest Deal Amount
  • Investors
  • 10

Aston Sci General Information

Description

Operator of a clinical-stage biopharmaceutical company intended to help to prolong the lives and improve the quality of life of many patients through medical innovation. The company focuses on basic research, clinical development and commercialization of various drugs such as therapeutic cancer vaccine, one of the ultimate cancer immunotherapy methods, anticancer drugs that control protein metabolism of cancer cells, and drugs for the central nervous system and geriatric diseases, helping the doctors to relieve the patients of pain as soon as possible.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Primary Office
  • 10th Floor, 40
  • Seolleung-ro 90-gil
  • Seoul, Gangnam-gu 06193
  • South Korea
+82 00-0000-0000

Aston Sci Timeline

2019202020212022
Financing RoundFinancing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Aston Sci Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series C) 01-Dec-2021 $22.8M 000.00 Completed Generating Revenue
3. Early Stage VC 01-Aug-2021 Completed Generating Revenue
2. Early Stage VC (Series B) 01-Nov-2020 Completed Startup
1. Early Stage VC (Series A) 01-Nov-2019 Completed Startup
To view Aston Sci’s complete valuation and funding history, request access »

Aston Sci Executive Team (9)

Name Title Board Seat Contact Info
Heon Jeong Ph.D Co-Founder, Co-Chief Executive Officer & Board Member
Heonwoo Shin Ph.D Co-Founder, Co-Chief Executive Officer, President, Chief Business Officer & Board Member
Jeong In-hyuk Chief Financial Officer & Board Member
Kim Byung-min Chief Operating Officer
Hyo-Hyun Park Chief Scientific Officer
You’re viewing 5 of 9 executive team members. Get the full list »

Aston Sci Board Members (5)

Name Representing Role Since
Heon Jeong Ph.D Aston Sci Co-Founder, Co-Chief Executive Officer & Board Member 000 0000
Heonwoo Shin Ph.D Aston Sci Co-Founder, Co-Chief Executive Officer, President, Chief Business Officer & Board Member 000 0000
Jeon Jeon Aston Sci Board Member 000 0000
Jeong In-hyuk Aston Sci Chief Financial Officer & Board Member 000 0000
Song Min-seop Aston Sci Board Member 000 0000
To view Aston Sci’s complete board members history, request access »

Aston Sci Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Gilt Edge Venture Capital Minority 000 0000 000000 0
JC Asset Management Venture Capital Minority 000 0000 000000 0
Lakewood Partners PE/Buyout Minority 000 0000 000000 0
Mirae Asset Global Investments Asset Manager Minority 000 0000 000000 0
ID Ventures (South Korea) Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »